Aurux Limited – Pharmaceutical Company & Financial Performance Review

Executive Summary

Describe about the “Acrux limited”.
 

The below analysis has been done with an intention to understand the financial statement structure and understand how the same has been used in the decision making process by the users. For the below analysis work AURUX Limited has been considered which is a publicly listed company traded in the Australian Stock exchange.

Aurux limited is a pharmaceutical company which is engaged in the drug development exercise. The management of the company through the use of its proprietary drug delivery technology has focused on commercialisation of its topical products. The company was incorporated in the year 1998. The company is very popular in US and Europe and has successfully licensed and developed a range of pharmaceutical products in these countries. The company later on in the year 2004 was listed in the Australian stock exchange. The company is engaged in carrying out necessary research and development work for the drug and is consistently working on a range of generic and patent-preferred products. The company is majorly working on marketing its three major products which includes:

• Axiron
• Evamist
• Lenzetto

These three products are approved by the authorities and thus are well marketed by the company. The management of the company is on a continuous basis leveraging with its Onsite laboratories, commercial and clinical experience and GMP manufacturing suite to introduce new product in the market.

The development process of the company includes:

• Analytical method development and validation
• Container closure selection
• Manufacturing scale-up and technical transfer to commercial-scale facilities
• Performing CMC activities, studies and reports for regulatory submissions
• Applicator or device development
• Extractables and leachables testing
• Stability testing

The company because of its extraordinary contribution to the medical field has been awarded twice with the 2010 Governor of Victoria Export Awards. Further for its Innovation Excellence, the company has been awarded with the Victorian Export Award. In the year 2010, the company for the product Axiron has signed the largest single product deal in the Australian history of biotechnology 

The balance sheet of the company provides information about the financial performance of the company. It contains information about the asset and liabilities that has been owned by the company. The asset and liabilities of the company are bifurcated by the short term and long term classification. The information contained in the balance sheet is being used by the users for decision making purposes.

The major heads of balance sheet in case of Acrux limited for the two year ended 2015 and 2014 are as follows:

Particular (in thousands)	2014	2015	Change	% change
Cash and cash equivalents	$         25,775	$         23,068	$         (2,707)	-11%
Receivables	$            5,488	$            4,826	$             (662)	-12%
Prepaid expenses	$               116	$               117	$                    1	1%
Total current assets	$         31,379	$         28,011	$         (3,368)	-11%
Non-current assets
Gross property, plant and equipment	$         21,679	$            1,332	$       (20,347)	-94%
Accumulated Depreciation	$               (88)	$         (1,240)	$         (1,152)	1309%
Intangible assets	$               251	$         20,392	$         20,141	8024%
Total non-current assets	$         21,842	$         20,484	$         (1,358)	-6%
Current liabilities
Accounts payable	$               217	$               106	$             (111)	-51%
Deferred income taxes	$            4,526	$            1,764	$         (2,762)	-61%
Other current liabilities	$            1,313	$            1,332	$                  19	1%
Total current liabilities	$            6,056	$            3,202	$         (2,854)	-47%
Non-current liabilities
Deferred taxes liabilities	$            5,097	$            4,649	$             (448)	-9%
Other long-term liabilities	$                  11	$                  19	$                    8	73%
Total non-current liabilities	$            5,108	$            4,668	$             (440)	-9%
Stockholders’ equity
Common stock	$         95,873	$         95,873	$                   –	0%
Retained earnings	$       (54,454)	$       (56,442)	$         (1,988)	4%
Accumulated other comprehensive income	$               638	$            1,194	$               556	87%
Total stockholders’ equity	$         42,057	$         40,625	$         (1,432)	-3%

The current asset of the company includes cash and cash equivalent, accounts receivables and prepaid expenses. Out of the total current asset, cash and cash equivalent contributes nearly 80% of the total assets. The cash balance of the company is consistent over the period of last 5 years. There has been huge reduction in the revenue numbers of the company. The revenue of the company has decreased by 53% in the year 2015 as compared to the previous year. However, with decrease in revenue numbers, the account receivable balances of the company haven’t seen a downfall. On the other hand, in case of prepaid expense, the balance standing in the books sounds immaterial from the perspective of the company. The non-current assets of the company are majorly contributed by the property, plant and equipment and intangible assets. There has been no major change being witnessed in the property, plant and equipment balance in the current year 2015 as compared to the previous year. The property, plant and equipment balances have been reduced considerably in the last two years. On the other hand, the intangible asset balances of the company have increased by 80% in the last two years. The high intangible asset standing in the books of the company is majorly on account of the expenses capitalised in the books for medicines like Axiron and Ellavie. The major heads capitalised in this case includes external research and development expenses, capitalisation of employee benefits and other capitalised amounts. The company is continuously making further investment in these medicines which in overall increasing the capitalised base of the company for these medicines. The amount so capitalised is being amortised over the period of coming 15 years.

Review of Financial Performance of the Company

The current liability of the company includes accounts, current tax payable by the company and short term provision. The current tax payable by the company has reduced considerably in the year 2015 by 61% as compared to the previous year; this is majorly on account of reduction in the profit for the company. The short term provision of the company includes provision for employee entitlements. The same is consistent and rotates with employee retrenchments.

The non-current liabilities portion is being is covered by the deferred tax liabilities and other liabilities. The deferred tax liabilities by its very nature have been classified as non-current. The deferred tax liabilities balance decreased by 8% over the period. This decrease is majorly on account of intangible assets. The long term provision of the company includes provision for employee entitlements. The same is consistent and rotates with employee retrenchments.

The shareholders equity consists of contributed equity, reserves and accumulated losses for the company. There has been no change in the equity balance of the company from past 2 years. However, the company has witnessed loss in the year 2015 which has increased the accumulated loss balance in the year.

When the financial ratio calculated on the balance sheet numbers, it has been noted that the current ratio and quick ratio of the company has shown improvement in the year 2015 as compared to the previous year.

The Income statement of the company provides information about the profit or loss earned by the Company. It contains the information relating to expenses done by the company during the financial year and income earned by the company during the year. All the taxes paid by the company during the year are deducted from the income earned by the Company to ascertain the net income earned by the Company during the year. It helps investors to know the profit earned by the company as compared to last year. If the company earns profit then investors intends to make investments in the Company and if the income statement shows huge losses then company losses the investors. Hence, the Income statement should provide the true and fair picture of the financials of the company so that investors can make the decision relating to investment easily.

Particulars in Million AUD	2014-06	2015-06	Change	Change%
Revenue	$ 53	$ 25	$ -28	-52.83%
Cost of revenue	$ 2	$ 1	$ -1	-50.00%
Gross profit	$ 52	$ 24	$ -28	-53.85%
Sales, General and administrative	$ 4	$ 5	$ 1	25.00%
Other operating expenses	$ 4	$ 2	$ -2	-50.00%
Total operating expenses	$ 8	$  8	$  0	0.00%
Operating income	$ 43	$ 17	$ -26	-60.47%
Income before taxes	$ 44	$ 17	$ -27	-61.36%
Provision for income taxes	$ 16	$ 6	$ -10	-62.50%
Net income from continuing operations	$ 28	$ 11	$ -17	-60.71%
Net income available to common shareholders	$ 28	$ 11	$ -17	-60.71%
Earnings per share
Basic	0.17	0.07	-0.1	-58.82%
Diluted	0.17	0.07	-0.1	-58.82%
Weighted average shares outstanding
Basic	167	167	0	0.00%
Diluted	167	167	0	0.00%
Earnings Before Income, Tax Depreciation and Amortization	$ 45	$ 17	-28	-62.22%

Revenue is the income earned by the company by selling’s its products without deducting the expenses. It is the income of the Company prior to the deduction of expenses and taxes. Revenue of the Acrux Limited has decreased from $ 53 Million to $ 25 Million which is around 53%. This shows that the sales of the Acrux Limited decreased as compare to last year. The profit of the Acrux Limited is affected due to down fall in revenue.

Cost of goods sold is the direct expense done by the company in producing and manufacturing the products. Cost of revenue of Acrux Limited is also decreases to 50% in year 2015 as compared to year 2014. The cost of the goods produced by the company has been reduced from the last year. During the year 2014 the Cost of goods sold is $ 2 Million which decreases to $ 1 million during the year 2015. This shows that the cost has been reduced by the Acrux Limited in producing the goods and products.

Operating expenses associated in the company is the indirect form of expenses. It includes Sales, general and administrative expenses along with other expenses. These expenses relates to selling the products manufactured by the Company. The Operating expenses of the Acrux Limited before income tax are $ 8 Million in year 2015 and 2014. There has been no changed in the operating expenses of the Acrux Limited. There is the consistency in the operating expenses of the Acrux Limited as compared to the last year.

Acrux Limited has not earned any non operating income during the year. Acrux Limited has not received any dividend from the companies in which it has invested and there is no gain from the foreign exchange earnings. Hence, the Acrux Limited has not gained or loosed any income in non operating earnings.

Operating income of the Acrux Limited has been reduced to $ 17 Million from $ 43 Million during the year 2015. There is about 60.47% change in the operating income during the year. It shows that the sales of the company have been reduced and it effects the performance of the company. The Acrux Limited has bear loss during the year 2015 as compared to year 2014.

Earning of the Company before income, taxes, depreciation and amortization has been reduced as compare to last year. During the year 2014 the Earning before income, taxes, depreciation and amortization is $ 45 Million which has been reduced to $ 17 Million in year 2015. This shows that the company faces loss during the year 2015.

Earnings per Share (EPS) depict the position of the Company. It shows whether the Company is profitable or not. Earnings per share are the portion left for the stakeholder or the earnings of the shareholders after deducting all expenses and taxes. An earnings per shares is the value given for per outstanding share of the Company. It is calculated by dividing Net profit available for the stakeholders by No. of outstanding stakeholders. Earnings per Share of the Acrux Limited have been reduced from 0.17 to 0.07 in year 2015. There has been about 59% change in the earnings per share of the Acrux Limited. The EPS of the Acrux Limited has reduced from the last year which shows that the profit available to the shareholders has been reduced. The Acrux Limited is giving fewer funds to the stakeholders as compared to last year. It also affects the decision criteria of the investors. 

The Cash flow statement of the company provides information about the cash inflow and cash outflow of the Company during the financial year. It informs about the expenses and investments done by the Company during the year in which the cash is out flowed and the cash made by the company by operating, investing and financing activities of the Company. There are three types of activities which depicts the cash inflow and outflow:-

1. Net Cash inflow (Outflow) from operating activities
2. Net Cash inflow (Outflow) from investing activities
3. Net Cash inflow (Outflow) from financing activities

Particulars in Million AUD	2014-06	2015-06
Cash Flows From Operating Activities
Other non-cash items	36	11
Net cash provided by operating activities	36	11
Cash Flows From Investing Activities
Investments in property, plant, and equipment	0	0
Property, plant, and equipment reductions
Other investing activities
Net cash used for investing activities	0	0
Cash Flows From Financing Activities
Common stock issued
Dividend paid	-33	-13
Net cash provided by (used for) financing activities	-33	-13
Effect of exchange rate changes	0	0
Net change in cash	3	-3
Cash at beginning of period	23	26
Cash at end of period	26	23

Cash earned from the operating activities is $ 11 Million which is less as compared to cash earned in last year. During last year 2014 Acrux Limited has inflow of $ 36 million which has been reduced during the current year. During the year the cash inflow is less in Acrux Limited as compare to the year 2014.

Cash inflow (outflows) from the investing activities is zero. Acrux Limited has not made any investments during the year. The company has not purchases and sold any of its capital assets during the year. Company has not made any type of investment during the current year and last year.

Cash inflow (outflows) from the financing activities is $ -13 million. The Company has spent the cash in financing activities. During the Year 2015, the outflow of the cash is less from financing activities as compared to 2014. During 204 the outflow is about $ (33) Million which is more than twice of outflow of current year.

Net change in Cash is reduced as compare to change in cash in last year. During last year 2014, the net change in cash is $ 3 Million which has been reduced by about 400 %.

The Stakeholders’ Equity of the company provides information relating to the money available for the distribution of income to the shareholders after deducting the taxes. It helps in determining the Earnings per share of the company. Stakeholder’s equity is calculated after deducting all the expenses from the accumulated income of the Company. In the present Company Acrux Limited the common stock is similar in both the year. Company does not issue any bonus shares during the year 2015. The Common stock available to the stakeholders’ of the Acrux Limited is $ 95, 873 Thousand. Retained loss is available for the stakeholders. The Acrux Limited has the negative retained earnings as the Company has loss during the year. There has been decrease in loss by 4% during the year 2015. Accumulated income has also increased during the year 2015. In year 2014 accumulated income is around $638 thousand which increases by $ 556 thousand in year 2015. There has been about 87% increase in the accumulated income during the year 2015.  The overall stakeholders’ equity is decrease by $(1,432) thousand during the year 2015. The stockholders equity during the year 2014 is $42057 which has been reduced to $ 40625 thousand.

Net Income available for the shareholder during the year 2015 is $11 Million. It has been reduced by 60.71% as compared to last year. Earnings per share are reduced to 0.07 from 0.17. As the company faces the loss during the year so the earnings per share has been reduced to 0.07.

In weighted average share outstanding earnings per share is 167. The basic weighted average share outstanding earnings do not change during the year 2014 and 2015. It is constant during the year 2014 and 2015. A diluted weighted average share outstanding earnings is also constant in the year 2015. There is no increase and decrease in the basic and diluted weighted average share outstanding earnings during the year 2014 and 2015. 

Conclusion

On the basis of above analysis it can be concluded that the Company Acrux Limited is facing diminishing economy as the revenue of the company decreases during the current year which results in low profits to the Company. Financial position of the company is not so good. Company has not made any investments during the last two years. Cash and cash balance of the company has been reduced during the year. Gross plant, machinery and equipment of the company have been diminished during the year 2015 as compared to year 2014. Cash flow of the Acrux Limited shows the outflow of the cash during the year. Operating profit, Gross profit and net profit available to the stakeholders has been reduced during the year 2015. Hence, the performance of the company has been decreased from the last year as the sales of the Acrux Limited have been decreased during the year. Investors will not attract towards the Acrux Limited to make the investments as the company does not have retained earnings. 

References:

• Morning Star, ‘Cash flow of Acrux Limited’, Viewed on May 24^th, 2016.
• Morning Star, ‘Balance sheet of Acrux Limited’, Viewed on May 24^th, 2016.
• Morning Star, ‘Income statement of Acrux Limited’, Viewed on May 24^th, 2016.